Chronic Daily Headache: A Rational-Approach to a Challenging Problem

Seminars in Neurology

Volumn 23, Issue 3, 2003, Pages 265-275

  Gladstone, Jonathan ^a   Eross, Eric ^a   Dodick, David ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic daily headache; Cluster headache; Medication overuse headache; Migraine

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; BARBITURIC ACID DERIVATIVE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BUTALBITAL; CAFFEINE; CODEINE; CORTICOSTEROID; DIHYDROERGOTAMINE; ERGOTAMINE; FLUOXETINE; GABAPENTIN; INDOMETACIN; METHYLPREDNISOLONE; NEFAZODONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYGEN; STEROID; SUMATRIPTAN; TIZANIDINE; TOPIRAMATE; VALPROATE SEMISODIUM; ZOLMITRIPTAN;

ADULT; BRAIN DEPTH STIMULATION; CHRONIC DISEASE; CONSTIPATION; DIAGNOSTIC APPROACH ROUTE; DIPLOPIA; DISEASE CLASSIFICATION; DRUG OVERDOSE; DRUG USE; EDEMA; EXPERIENCE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPOTENSION; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MUSCLE WEAKNESS; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROBLEM SOLVING; PTOSIS; PUBLIC HEALTH; QUALITY OF LIFE; REPETITIVE STRAIN INJURY; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SUNCT SYNDROME; SYNDROME DELINEATION; TAXONOMY;

ADULT; ANTIEMETICS; BLOOD PATCH, EPIDURAL; CLINICAL PROTOCOLS; CLUSTER HEADACHE; DIAGNOSIS, DIFFERENTIAL; DIHYDROERGOTAMINE; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HEADACHE DISORDERS; HEALTH SERVICES MISUSE; HUMANS; INTRACRANIAL HYPERTENSION; LIFE CHANGE EVENTS; MAGNETIC RESONANCE IMAGING; MALE; METOCLOPRAMIDE; PATIENT EDUCATION; SPINAL PUNCTURE; SUBSTANCE-RELATED DISORDERS; TRIGEMINAL NEURALGIA; VASOCONSTRICTOR AGENTS;

EID: 0347478275     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-814738     Document Type: Review

References (45)

1. Scher AI, Stewart WF, Liberman J, et al. Prevalence of frequent headache in a population sample. Headache 1998; 38:497-506
2. Castillo J, Munoz J, Guitera V, et al. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-196
3. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology 2000;54:314-319
4. Pascual J, Colas R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001;5:529-536
5. Lanteri-Minet M, Auray JP, El Hasnaoui A. Prevalence and description of chronic daily headache in the general population of France. Pain 2003;102:143-149
6. Mathew NT. Chronic refractory headache. Neurology 1993; 43(suppl 3):S26-S33
7. D'Amico D, Usai S, Grazzi L, et al. Quality of life and disability in primary chronic daily headache. Neurol Sci 2003; 24:S97-S100
8. Guitera V, Munoz P, Castillo J, et al. Quality of life in chronic daily headache. A study in general population. Neurology 2002;58:1062-1065
9. Wang SJ, Fuh JL, Lu SR, et al. Quality of life differs among headache diagnoses: analysis of SF-35 survey in 901 headache patients. Pain 2001;89:285-292
10. Welch KM, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 2002;15:287-295
11. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia 2004;24(suppl 1):1-160
12. Mokri B. Headaches caused by decreased intracranial pressure: diagnosis and management. Curr Opin Neurol 2003;16:319-326
13. Dodick DW, Mosek AC, Campbell JK. The hypnic ("alarm clock") headache syndrome. Cephalalgia 1998;18:152-156
14. Dodick D. Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia 2001;21:869-872
15. Peres MF, Silberstein SD, Nahmias S, et al. Hemicrania continua is not that rare. Neurology 2001;57:948-951
16. Rozen TD. New daily persistent headache. Curr Pain Headache Rep 2003;7:218-223
17. Tepper SJ. Analgesic overuse is a cause of chronic daily headache. Headache 2002;42:543-547
18. Dodick DW. Analgesic overuse is not a cause of chronic daily headache. Headache 2002;42;547-554
19. Dowson AJ, Dodick DW, Limmroth V. Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 2003 (in press)
20. Silverman K, Evans SM, Strain EC, et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992;327:1109-1114
21. Bahra A, Walsh M, Menon S, et al. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003;43;179-190
22. Young WB. Medication overuse headache. Curr Treat Options Neurol 2001;3:181-188
23. Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 1999;33:61-72
24. Boes C, Jones JM, Dodick SW. Self-administered subcutaneous dihydroergotamine in the outpatient treatment of chronic daily headache with medication overuse. Headache 2000;40:402
25. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982;22:66-68
26. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised HIS criteria. Neurology 1996;47:871-875
27. Matthew NT. Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurol Clin 1997;15:167-186
28. Scher A., Lipton RB, Stewart WF. Risk factors for chronic daily headache. Curr Pain Headache Rep 2002;6:486-491
29. Scher AI, Lipton RB, Stewart WF. Habitual snoring as a risk factor for chronic daily headache. Neurology 2003;60:1366-1368
30. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-1017
31. Tracey I, Ploghaus A, Gati JS, et al. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 2002;22:2748-2752
32. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762
33. Brandes JL, Jacobs D, Neto W, et al. Topiramate in the prevention of migraine headache: a randomized, double-blind, placebo-controlled, parallel study (MIGR-002). Neurology 2003;60:A238
34. Mathew NT, Schmitt J, Jacobs D, et al. Topiramate in migraine prevention (MIGR-001): effect on migraine frequency. Neurology 2003:60:A336
35. Ondo WG, Vuong KD, Derman HS. Botulinum toxin A (BOTOX®) for chronic daily headache: a randomized placebo-controlled, parallel design study. Cephalalgia 2003 (in press)
36. Freitag FG, Collins SD, Carlson HA, et al. Depakote ER Migraine Study Group. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002;58:1652-1659
37. Storer RJ, Goadsby PJ. Topiramate inhibits trigeminovascular traffic in the cat: possible locus of action in the prevention of migraine. Neurology 2003;60(S1):A238-A239
38. Cui M, Aoki KR. Botulinum toxin type A (BONT/A) reduces inflammatory pain in the rat formalin model. Cephalalgia. 2000;20:414
39. Cui M, Li S, You S, Khanijou S, Aoki KR. Mechanisms of the antinociceptive effect of subcutaneous Botox inhibition of peripheral and central nociceptive processing. International Conference 2002 Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Hanover, Germany, June 8-11, 2002. Naunyn Schmiedebergs Arch Pharmacol 2002;365 (suppl 2):R17
40. Rosales RL, Arimura K, Ikenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection. Muscle Nerve 1996;19:488-496
41. Silberstein SD. Review of botulinum toxin type A and its clinical applications in migraine headache. Expert Opin Pharmacother 2001;2:1649-1654
42. Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep 2001;5:83-91
43. Dodick D, Rozen T, Goadsby P, Silberstein S. Cluster headache. Cephalalgia 2000;20:787-803
44. May A, Leone M. Update on cluster headache. Curr Opin Neurol 2003;16:333-340
45. Leone M, Franzini A, D'Amico A, et al. Preliminary results and follow up of stereotactic electrode implant in posterior hypothalamic gray matter to relieve intractable chronic cluster headache. Neurology 2002;58:89-90